Stereotaxis Inc Stock Other OTC
Equities
US85916J4094
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.55 USD | -36.72% | +10.41% | +272.80% |
Mar. 04 | Transcript : Stereotaxis, Inc., Q4 2023 Earnings Call, Mar 04, 2024 | |
Mar. 04 | Earnings Flash (STXS) STEREOTAXIS Reports Q4 Revenue $4.6M, vs. Street Est of $7.7M | MT |
Financials (USD)
Sales 2024 * | 30.88M | Sales 2025 * | 44.25M | Capitalization | 205M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -16M | EV / Sales 2024 * | 6.65 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.64 x |
P/E ratio 2024 * |
-10.6
x | P/E ratio 2025 * |
-13.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 16-09-28 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 02-12-31 |
Laura Garth
LAW | General Counsel | - | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 05-04-30 |
Chief Executive Officer | 57 | 16-09-28 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 17-02-02 |
1st Jan change | Capi. | |
---|---|---|
+6.05% | 209B | |
+8.80% | 175B | |
+10.11% | 131B | |
+18.30% | 99.98B | |
-0.91% | 61.12B | |
+14.25% | 52.34B | |
-4.15% | 46.5B | |
-1.65% | 39.24B | |
+10.19% | 38.47B |